Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy.

Sci Rep · 2025 · PMC12371022 · PMID 40841737

Europe PMC DOI

hedged sentences

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

did not reach statistical significanceP = 0.089so close (0.05 < p ≤ 0.1)

In the MTV-high group, OS was shorter but did not reach statistical significance [NR vs. 11.8 months (95% CI: 4.9–18.7), P = 0.089].

also in 111,027 other papers

showed a trendno p-value reported

Although de novo metastatic disease showed a trend toward poorer survival in univariate analysis, it did not remain significant in multivariate models.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.